| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | paclitaxel | CCLE | pan-cancer | AAC | 0.26 | 3e-08 |
| mRNA | Topotecan | CCLE | pan-cancer | AAC | 0.23 | 3e-07 |
| mRNA | Irinotecan | CCLE | pan-cancer | AAC | 0.21 | 0.0002 |
| mRNA | AEW541 | CCLE | pan-cancer | AAC | -0.13 | 0.005 |
| mRNA | TKI258 | CCLE | pan-cancer | AAC | 0.13 | 0.008 |
| mRNA | Sorafenib | CCLE | pan-cancer | AAC | 0.11 | 0.02 |
| mRNA | TAE684 | CCLE | pan-cancer | AAC | -0.08 | 0.09 |
| mRNA | Panobinostat | CCLE | pan-cancer | AAC | 0.068 | 0.1 |
| mRNA | 17-AAG | CCLE | pan-cancer | AAC | 0.069 | 0.2 |
| mRNA | L-685458 | CCLE | pan-cancer | AAC | 0.061 | 0.2 |